Riccardo De Giorgi

453 posts

Riccardo De Giorgi banner
Riccardo De Giorgi

Riccardo De Giorgi

@rdegiorgi

MD, DPhil, MRCPsych. Clinical Lecturer ST4-6 at University of Oxford, Department of Psychiatry

Oxford, England Katılım Ocak 2012
382 Takip Edilen288 Takipçiler
Riccardo De Giorgi retweetledi
Nicholas Fabiano, MD
Nicholas Fabiano, MD@NTFabiano·
Metabolic dysfunction is at the core of mental disorders. Exercise, diet & sleep are fundamental to mental health. Excited to serve as Guest Editor for this Topic Collection at BMJ Connections Mental Health.
Nicholas Fabiano, MD tweet media
English
34
140
1.1K
68.9K
Riccardo De Giorgi retweetledi
BMJ Mental Health
BMJ Mental Health@BMJMentalHealth·
🚀 We have a new companion title: BMJ Connections Mental Health An open access journal publishing the full spectrum of robust, reproducible, original research. Get the first articles delivered to your inbox. Sign up here: emails.bmj.com/k/Bmj/jausu/bm… #OpenAccess
BMJ Mental Health tweet media
English
0
1
8
350
Riccardo De Giorgi retweetledi
BMJ Mental Health
BMJ Mental Health@BMJMentalHealth·
Just launched: #BMJ Connections Mental Health, a new open access #journal from BMJ for #researchers, #clinicians & #funders advancing #global #mentalhealth From #lab to #clinic, #realworld impact starts here. @Rethink_ @NIMHgov @mentalhealthuk @APA @GPsych_BMJ @psychiatry_ucam @MedscapePsych @rcpsych 👇🏼Read the editorial: mentalhealth.bmj.com/content/28/1/e… #MentalHealth #OpenAccess #BMJConnections
BMJ Mental Health tweet media
English
1
7
31
3K
Riccardo De Giorgi retweetledi
Roger S. McIntyre, MD, FRCPC
Roger S. McIntyre, MD, FRCPC@rogersmcintyre·
I’ve been frequently asked by colleagues globally about the risk of suicidality associated with glucagon-like peptide-1 receptor agonists GLP-1 -RAs (eg semaglutide,tirzepatide) . This publication is a state of the union on the topic. pubmed.ncbi.nlm.nih.gov/40859700/
English
0
6
19
1.3K
Riccardo De Giorgi
Riccardo De Giorgi@rdegiorgi·
Congrats to a great research team Ana Ghenciulescu, Anna Pearse, Amedeo Minichino, Gaia Sampogna Andrea Fiorillo, who have made this study possible
English
0
0
0
59
Riccardo De Giorgi
Riccardo De Giorgi@rdegiorgi·
📖 In summary, our findings suggest that lurasidone is a useful psychopharmacological tool for treating depressive symptoms in patients with severe mental illness, supporting the current evidence-base which has, to date, guided clinical recommendations based on expert opinion 📖
English
1
0
0
67
Riccardo De Giorgi
Riccardo De Giorgi@rdegiorgi·
Take a look at our new open-access paper “Transdiagnostic efficacy of lurasidone on depressive symptoms: systematic review and meta-analysis of randomised controlled trials” doi.org/10.1192/bjp.20… on @BJPsych!
Riccardo De Giorgi tweet media
English
1
1
1
136
Riccardo De Giorgi retweetledi
No Context Brits
No Context Brits@NoContextBrits·
Petition to make Matt Berry the next James Bond.
No Context Brits tweet media
English
1.8K
2.7K
35.6K
3M
Thomas Reilly
Thomas Reilly@Rational_Psych·
I have questions
Thomas Reilly tweet media
English
3
0
4
375
Amanda I Adler
Amanda I Adler@DrAmandaAdler·
Very much looking forward to supporting publicly funded research that informs important unanswered questions 💐
National Institute for Health and Care Research@NIHRresearch

Congratulations to Professor @DrAmandaAdler, Professor of Diabetic Medicine and Health Policy at the Radcliffe Department of Medicine, @UniofOxford on her new appointment as the Chair of the Clinical Evaluation and Trials funding committee for our Health Technology Assessment (HTA) Programme. Professor Adler takes over the role from Professor Wu, William R Lindsay Chair of Health Economics at the University of Glasgow, following her becoming Programme Director of the joint NIHR and MRC Better Methods, Better Research (BMBR) Programme.

English
19
1
50
3.3K